IJCNMH ARCpublishing
ADVANCED SEARCH


Issue: Issue 3 (2016) – Supplement 1


Lecture

Regulation of translation of Ataxin-3 by Ataxin-2

Author(s):
Clévio Nóbrega, Sara Carmo-Silva, David Albuquerque, Ana Vasconcelos- Ferreira, Udaya-Geetha Vijayakumar, Liliana Mendonça, Hirokazu Hirai, and Luís Pereira de Almeida
Abstract:
In polyglutamine disorders, proteins carrying abnormally long polyglutamine tracts interact aberrantly with other proteins contributing to neurodegeneration. In this work we focus on Machado-Joseph disease (MJD), a disorder associated to the polyglutamine-expanded ataxin-3 (Atx3MUT). Aiming at clarifying the mechanism of neurodegeneration we investigated the interaction of Atx3MUT with wild-type ataxin-2, a protein recently involved in ALS and PD pathogenesis, and whose mutated form causes spinocerebellar ataxia type 2. Using cell and animal models of MJD, we found that Atx3MUT aggregation in the cell nucleus leads to re-location of Atx2 to the nucleus and a downregulation of its mRNA and protein levels. Importantly, our results suggest a role of Atx2 in translational regulation of specific transcripts, by reducing the protein synthesis through interaction with PABP. Accordingly, abnormal reduction of Atx2 cytoplasmic levels, by freeing its natural interactor and translation activator PABP, leads to an overactive protein translation of specific transcripts, particularly of Atx3MUT. Conversely, the restoration of Atx2 levels represses Atx3MUT translation and rescues neuropathological MJD-related abnormalities, due to interaction with PABP through PAM2 motif. These data indicate a clear function of Atx2 in the regulation of the translation of specific mRNAs, particularly ataxin-3 and point to a key physiological role of ataxin-2 in MJD pathogenesis opening a new avenue for therapeutic intervention in this and potentially other polyglutamine disorders.

Special Issue on Controversies in Neurology. From the 10th World Congress on Controversies in Neurology (CONy), Lisbon, Portugal. 17–20 March 2016.

International Journal of Clinical Neurosciences and Mental Health 2016; 3(Suppl. 1):L33
Icon_pdf Download PDF